{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:25:43Z","timestamp":1792481143986,"version":"4.5.0"},"reference-count":53,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Scientific Research, Imam Mohammad Ibn Saud Islamic University","award":["221412025"],"award-info":[{"award-number":["221412025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Trans-[Cu (quin)2(EtOH)2], a new copper (II) complex, was characterized using a variety of computational techniques to explore its biological role in pharmacological applications. Methods: The computational methods included density functional theory (DFT), ADMET and molecular docking. Results: The optimized geometrical parameters revealed that the plane containing the Cu ion and the Quinaldinate ligands was confirmed to be nearly planar. DFT findings suggest that the complex has a stable structure with a moderate band gap of 3.88 eV. Highest Occupied Molecular Orbital (HOMO) and the Lowest Unoccupied Molecular Orbital (LUMO) analysis revealed a planar surface intramolecular charge transfer from its donor sites, in the center, to its ends instead of the vertical plane. Two electron-rich regions were observed around the oxygen ions in the molecular electrostatic potential (MEP) map, which were expected to be the sites of molecular bonding and interactions with target proteins. Drug-likeness and pharmacokinetics parameters were determined to provide insight into the safety level of the studied compound. The ADMET (absorption, distribution, metabolism, excretion, and toxicity) results showed favorable pharmacological features, as evidenced by a high oral bioavailability and a low risk of toxicity. A molecular docking study was performed by fitting the copper complex into the active sites of target proteins for Bacillus cereus, Staphylococcus aureus, and Escherichia coli bacteria. The title complex had the strongest antifungal effect within the inhibitory zone of B. cereus with a strong binding affinity of \u20139.83 kcal\/mol. Also, maximum activity was exhibited against S.aureus (\u20136.65 kcal\/mol) compared to the other recently reported Cu complexes within the limits of the screened references. Docking studies implicated modest inhibitory activity against E. coli bacteria. Conclusions: The findings highlighted the compound\u2019s biological activities and identified it as a possible treatment drug for the bacteria B. cereus and S. aureus.<\/jats:p>","DOI":"10.31083\/j.fbl2804084","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:26:41Z","timestamp":1682587601000},"source":"Crossref","is-referenced-by-count":6,"title":["Studying the Biological Activity of Trans-[Cu (quin)2(EtOH)2] as Potent Antimicrobial Cu(II) Complex through Computational Investigations: DFT, ADMET and Molecular Docking"],"prefix":"10.31083","volume":"28","author":[{"given":"Rageh K.","family":"Hussein","sequence":"first","affiliation":[{"name":"Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623 Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Khayatt","sequence":"first","affiliation":[{"name":"Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623 Riyadh, Saudi Arabia"},{"name":"Reactor Physics Department, Nuclear Research Centre, Atomic Energy Authority, 13759 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar K. Al","family":"Duaij","sequence":"first","affiliation":[{"name":"Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623 Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Alkaoud","sequence":"first","affiliation":[{"name":"Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623 Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nature Reviews. Drug Discovery. 2021; 20: 200\u2013216.","DOI":"10.1038\/s41573-020-00114-z"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Frontiers in Pharmacology. 2021; 12: 618411.","DOI":"10.3389\/fphar.2021.618411"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Duncan C, White AR. Copper complexes as therapeutic agents. Metallomics: Integrated Biometal Science. 2012; 4: 127\u2013138.","DOI":"10.1039\/C2MT00174H"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hussain A, AlAjmi MF, Rehman MT, Amir S, Husain FM, Alsalme A, et al. Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies. Scientific Reports. 2019; 9: 5237.","DOI":"10.1038\/s41598-019-41063-x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"AlAjmi MF, Hussain A, Rehman MT, Khan AA, Shaikh PA, Khan RA. Design, Synthesis, and Biological Evaluation of Benzimidazole-Derived Biocompatible Copper(II) and Zinc(II) Complexes as Anticancer Chemotherapeutics. International Journal of Molecular Sciences. 2018; 19: 1492.","DOI":"10.3390\/ijms19051492"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kraj\u010diov\u00e1 D, Meln\u00edk M, Havr\u00e1nek E, Forg\u00e1csov\u00e1 A, Miku\u0161 P. Copper compounds in nuclear medicine and oncology. Journal of Coordination Chemistry. 2014; 67: 1493\u20131519.","DOI":"10.1080\/00958972.2014.915966"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Badea M, Uivarosi V, Olar R. Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix. Molecules. 2020; 25: 5830.","DOI":"10.3390\/molecules25245830"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Haas KL, Franz KJ. Application of metal coordination chemistry to explore and manipulate cell biology. Chemical Reviews. 2009; 109: 4921\u20134960.","DOI":"10.1021\/cr900134a"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Tabasi H, Babaei M, Abnous K, Taghdisi SM, Saljooghi AS, Ramezani M, et al. Metal\u2013polymer-coordinated complexes as potential nanovehicles for drug delivery. Journal of Nanostructure in Chemistry. 2021; 11: 501\u2013526.","DOI":"10.1007\/s40097-021-00432-7"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Silversides JD, Allan CC, Archibald SJ. Copper(II) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis. Dalton Transactions. 2007; 971\u2013978.","DOI":"10.1039\/b615329a"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Helsel ME, Franz KJ. Pharmacological activity of metal binding agents that alter copper bioavailability. Dalton Transactions (Cambridge, England: 2003). 2015; 44: 8760\u20138770.","DOI":"10.1039\/C5DT00634A"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Noreen S, Sumrra SH. Correlating the charge transfer efficiency of metallic sulfa-isatins to design efficient NLO materials with better drug designs. Biometals. 2022; 35: 519\u2013548.","DOI":"10.1007\/s10534-022-00385-6"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Briffa J, Sinagra E, Blundell R. Heavy metal pollution in the environment and their toxicological effects on humans. Heliyon. 2020; 6: e04691.","DOI":"10.1016\/j.heliyon.2020.e04691"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lucaciu RL, Hangan AC, Sevastre B, Oprean LS. Metallo-Drugs in Cancer Therapy: Past, Present and Future. Molecules. 2022; 27: 6485.","DOI":"10.3390\/molecules27196485"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Schlick T, Portillo-Ledesma S. Biomolecular modeling thrives in the age of technology. Nature Computational Science. 2021; 1: 321\u2013331.","DOI":"10.1038\/s43588-021-00060-9"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Zhang Y, Luo M, Wu P, Wu S, Lee TY, Bai C. Application of Computational Biology and Artificial Intelligence in Drug Design. International Journal of Molecular Sciences. 2022; 23: 13568.","DOI":"10.3390\/ijms232113568"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development. CPT: Pharmacometrics & Systems Pharmacology. 2012; 1: e6.","DOI":"10.1038\/psp.2012.4"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kapetanovic IM. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chemico-biological Interactions. 2008; 171: 165\u2013176.","DOI":"10.1016\/j.cbi.2006.12.006"},{"key":"ref19","unstructured":"Franz JH, Michael RG, Michael KP. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays (pp. 1241). Springer Berlin Heidelberg: Berlin, Heidelberg. 2013."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wishart DS. Improving early drug discovery through ADME modelling: an overview. Drugs in R&D. 2007; 8: 349\u2013362.","DOI":"10.2165\/00126839-200708060-00003"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Hsiao Y, Su BH, Tseng YJ. Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development. Briefings in Bioinformatics. 2021; 22: bbaa160.","DOI":"10.1093\/bib\/bbaa160"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X, et al. Computational Approaches in Preclinical Studies on Drug Discovery and Development. Frontiers in Chemistry. 2020; 8: 726.","DOI":"10.3389\/fchem.2020.00726"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wong F, Krishnan A, Zheng EJ, St\u00e4rk H, Manson AL, Earl AM, et al. Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery. Molecular Systems Biology. 2022; 18: e11081.","DOI":"10.15252\/msb.202211081"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Pinzi L, Rastelli G. Molecular Docking: Shifting Paradigms in Drug Discovery. International Journal of Molecular Sciences. 2019; 20: 4331.","DOI":"10.3390\/ijms20184331"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015; 20: 13384\u201313421.","DOI":"10.3390\/molecules200713384"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ma DL, Chan DSH, Leung CH. Molecular docking for virtual screening of natural product databases. Chemical Science. 2011; 2: 1656\u20131665.","DOI":"10.1039\/C1SC00152C"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Podjed N, \u010crepin\u0161ek J, Modec B. Trans-[Cu(quin)2(EtOH)2]. Molbank. 2021; 2021: M1216.","DOI":"10.3390\/M1216"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Roy LE, Hay PJ, Martin RL. Revised Basis Sets for the LANL Effective Core Potentials. Journal of Chemical Theory and Computation. 2008; 4: 1029\u20131031.","DOI":"10.1021\/ct8000409"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hassan AU, Sumrra SH. Exploring the Bioactive Sites of New Sulfonamide Metal Chelates for Multi-Drug Resistance: An Experimental Versus Theoretical Design. Journal of Inorganic and Organometallic Polymers and Materials. 2022; 32: 513\u2013535.","DOI":"10.1007\/s10904-021-02135-6"},{"key":"ref30","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian-09. Revision A.02. Gaussian, Inc.: Wallingford, CT. 2009."},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Yang Y, Weaver MN, Merz KM, Jr. Assessment of the \u201c6-31+G** + LANL2DZ\u201d mixed basis set coupled with density functional theory methods and the effective core potential: prediction of heats of formation and ionization potentials for first-row-transition-metal complexes. The Journal of Physical Chemistry. A. 2009; 113: 9843\u20139851.","DOI":"10.1021\/jp807643p"},{"key":"ref32","unstructured":"Dennington R, Keith T, Millam J. Gauss View. Semichem Inc.: Shawnee, KS, USA. 2009."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Radchenko EV, Rulev YA, Safanyaev AY, Palyulin VA, Zefirov NS. Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components. Doklady. Biochemistry and Biophysics. 2017; 473: 128\u2013131.","DOI":"10.1134\/S1607672917020107"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Dyabina AS, Radchenko EV, Palyulin VA, Zefirov NS. Prediction of blood-brain barrier permeability of organic compounds. Doklady. Biochemistry and Biophysics. 2016; 470: 371\u2013374.","DOI":"10.1134\/S1607672916050173"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009; 30: 2785\u20132791.","DOI":"10.1002\/jcc.21256"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kemmish H, Fasnacht M, Yan L. Fully automated antibody structure prediction using BIOVIA tools: Validation study. PLoS ONE. 2017; 12: e0177923.","DOI":"10.1371\/journal.pone.0177923"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Bitencourt-Ferreira G, de Azevedo WF, Jr. Molegro Virtual Docker for Docking. Methods in Molecular Biology. 2019; 2053: 149\u2013167.","DOI":"10.1007\/978-1-4939-9752-7_10"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Podjed N, Modec B, Cl\u00e9rac R, Rouzi\u00e8res M, Alcaide MM, L\u00f3pez-Serrano J. Structural diversity and magnetic properties of copper (II) quinaldinate compounds with amino alcohols. New Journal of Chemistry. 2022; 46: 6899\u20136920.","DOI":"10.1039\/D2NJ00296E"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Podjed N, Modec B, Alcaide MM, L\u00f3pez-Serrano J. From cyclic amines and acetonitrile to amidine zinc(ii) complexes. RSC Advances. 2020; 10: 18200\u201318221.","DOI":"10.1039\/D0RA03192E"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Benet LZ, Hosey CM, Ursu O, Oprea TI. BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews. 2016; 101: 89\u201398.","DOI":"10.1016\/j.addr.2016.05.007"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Poongavanam V, Atilaw Y, Ye S, Wieske LHE, Erdelyi M, Ermondi G, et al. Predicting the Permeability of Macrocycles from Conformational Sampling - Limitations of Molecular Flexibility. Journal of Pharmaceutical Sciences. 2021; 110: 301\u2013313.","DOI":"10.1016\/j.xphs.2020.10.052"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Tsantili-Kakoulidou A, Demopoulos VJ. Drug-like Properties and Fraction Lipophilicity Index as a combined metric. ADMET & DMPK. 2021; 9: 177\u2013190.","DOI":"10.5599\/admet.1022"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Radchenko EV, Dyabina AS, Palyulin VA, Zefirov NS. Prediction of human intestinal absorption of drug compounds. Russian Chemical Bulletin. 2016; 65: 576\u2013580.","DOI":"10.1007\/s11172-016-1340-0"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Vilar S, Chakrabarti M, Costanzi S. Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. Journal of Molecular Graphics & Modelling. 2010; 28: 899\u2013903.","DOI":"10.1016\/j.jmgm.2010.03.010"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ahmed SSSJ, Ramakrishnan V. Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS ONE. 2012; 7: e40654.","DOI":"10.1371\/journal.pone.0040654"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kowalska M, Nowaczyk J, Nowaczyk A. KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity. International Journal of Molecular Sciences. 2020; 21: 8099.","DOI":"10.3390\/ijms21218099"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Schmidtke P, Ciantar M, Theret I, Ducrot P. Dynamics of hERG closure allow novel insights into hERG blocking by small molecules. Journal of Chemical Information and Modeling. 2014; 54: 2320\u20132333.","DOI":"10.1021\/ci5001373"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Hassan AU, Sumrra S H, Imran M, Chohan ZH. New 3d Multifunctional Metal Chelates of Sulfonamide: Spectral, Vibrational, Molecular Modeling, DFT, Medicinal and in Silico Studies. Journal of Molecular Structure. 2022; 1254: 132305.","DOI":"10.1016\/j.molstruc.2021.132305"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Hashem HE, Nath A, Kumer A. Synthesis, Molecular Docking, Molecular Dynamic, Quantum Calculation, and Antibacterial Activity of New Schiff Base-Metal Complexes. Journal of Molecular Structure. 2022; 1250: 131915.","DOI":"10.1016\/j.molstruc.2021.131915"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Kumer A, Chakma U, Islam MD T, Howlader D, Hossain T. The computational investigation of sixteen antiviral drugs against main protease (MPRO) and spike protease (SPRO) of SARS-COV-2. Journal of the Chilean Chemical Society. 2021; 66: 5339\u20135351.","DOI":"10.4067\/s0717-97072021000405339"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Noreen S, Sumrra SH, Chohan ZH, Mustafa G, Imran M. Synthesis, Characterization, Molecular Docking and Network Pharmacology of Bioactive Metallic Sulfonamide-Isatin Ligands against Promising Drug Targets. Journal of Molecular Structure. 2023; 1277: 134780.","DOI":"10.1016\/j.molstruc.2022.134780"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Devi GR, Rajack A, Sunkara SV, Karreddula R, Krishna GP, Surendra babu MS. Biological evaluation and photocatalytic activities of diaquabis pyrazine tetrazole metal complexes synthesised by microwave activation. Journal of Chemical Sciences. 2022; 134: 30.","DOI":"10.1007\/s12039-021-02023-z"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Johnson J, Yardily A. Spectral, modeling and biological studies on a novel (E)-3-(3 bromo-4-methoxyphenyl)-1-(thiazol-2-yl)prop 2-en-1-one and some bivalent metal(II) complexes. Journal of Molecular Structure. 2021; 1244: 130991.","DOI":"10.1016\/j.molstruc.2021.130991"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/4\/10.31083\/j.fbl2804084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:55:19Z","timestamp":1732712119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/4\/10.31083\/j.fbl2804084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2768-6701(23)00858-4"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2804084","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"article-number":"84"}}